Bide Pharmatech Co., Ltd. (SHA:688073)

Bide Pharmatech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	647.12	941.48	1,105	1,274	1,506	193.46
Trading Asset Securities	476.33	100.01	75.52	0.12	3.97	-
Cash & Short-Term Investments	1,123	1,041	1,181	1,274	1,510	193.46
Cash Growth	-2.24%	-11.80%	-7.33%	-15.61%	680.49%	43.70%
Accounts Receivable	291.53	261.14	227.37	237.35	177.37	124.68
Other Receivables	12.43	15.17	15.39	10.66	16.79	9.89
Receivables	303.96	276.32	242.76	248.01	194.16	134.57
Inventory	922.75	962.01	760.22	699.43	521.86	476.55
Prepaid Expenses	-	3.64	4.19	5.61	2.47	0.04
Other Current Assets	35.96	21.38	20.7	33.92	16.19	13.1
Total Current Assets	2,386	2,305	2,209	2,261	2,245	817.71
Property, Plant & Equipment	131.61	153.02	166.88	97.32	75.45	60.04
Goodwill	7.56	7.56	-	-	-	-
Other Intangible Assets	5.02	4.93	3.95	0.6	0.21	0.44
Long-Term Deferred Tax Assets	34.08	23.91	14.74	18.36	3.88	2.97
Long-Term Deferred Charges	13.68	19.7	23.74	37.58	16.81	22.13
Other Long-Term Assets	2.55	2.86	-	-	18.25	2.84
Total Assets	2,581	2,517	2,418	2,415	2,359	906.13

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	158.6	202.46	216.32	179.57	167.37	206.07
Accrued Expenses	25.83	44.35	31.38	36.26	30.1	18.57
Short-Term Debt	5.2	0.34	30.18	0.23	9.61	0.07
Current Portion of Long-Term Debt	18.92	4.55	-	-	-	-
Current Portion of Leases	-	14.6	14.06	15.88	-	-
Current Income Taxes Payable	43.88	19.22	12.85	6.49	6.22	8.39
Current Unearned Revenue	51.11	48.31	36.69	29.07	20.52	14.68
Other Current Liabilities	5.51	7.99	4.28	7.47	15.25	1.78
Total Current Liabilities	309.05	341.82	345.76	274.97	249.07	249.56
Long-Term Debt	78.75	83.25	-	-	-	-
Long-Term Leases	27.29	38.33	37.95	41.19	31.21	27.71
Long-Term Deferred Tax Liabilities	6.27	7.94	7.2	8.06	2.77	-
Other Long-Term Liabilities	0.05	0.07	-	1.27	-	-
Total Liabilities	421.4	471.4	390.91	325.49	283.05	277.27

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	90.88	90.88	90.88	90.88	64.92	48.69
Additional Paid-In Capital	1,790	1,793	1,755	1,754	1,776	483.24
Retained Earnings	427.51	363.51	289.63	252.08	242.48	96.51
Treasury Stock	-152.97	-199.98	-99.99	-	-	-
Comprehensive Income & Other	3.45	-1.63	-8.6	-6.96	-7.25	0.43
Shareholders' Equity	2,159	2,045	2,027	2,090	2,076	628.86
Total Liabilities & Equity	2,581	2,517	2,418	2,415	2,359	906.13

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	130.15	141.07	82.2	57.3	40.82	27.78
Net Cash (Debt)	993.29	900.41	1,099	1,217	1,469	165.68
Net Cash Growth	8.79%	-18.04%	-9.72%	-17.17%	786.71%	40.92%
Net Cash Per Share	11.43	10.27	12.35	13.44	19.93	2.47
Filing Date Shares Outstanding	86.67	86.15	88.33	90.88	90.88	68.16
Total Common Shares Outstanding	86.67	86.15	88.33	90.88	90.88	68.16
Working Capital	2,077	1,963	1,863	1,986	1,996	568.15
Book Value Per Share	24.91	23.74	22.95	22.99	22.84	9.23
Tangible Book Value	2,147	2,033	2,023	2,089	2,076	628.42
Tangible Book Value Per Share	24.77	23.60	22.91	22.98	22.84	9.22
Buildings	-	76.58	85.07	16.58	16.58	16.58
Machinery	-	66.68	45.93	47.23	35.62	21.9
Construction In Progress	-	-	15.41	-	5.1	-

Data Source: S&P Global Market Intelligence Last updated: Oct 12, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error